VCS tracks denial patterns across every supported payer to anticipate, prevent, and overturn. This page is the aggregated, anonymized record of what we've learned — and what it's worth to your practice.
All figures reflect historical aggregated performance from VCS-supported workflows. Anonymized, refreshed quarterly. Directional intelligence — not a guarantee of individual case outcomes. See Methodology section.
Anonymized payer profiles representing major national carriers, regional plans, and Medicare Advantage programs. Names are omitted by design — patterns are universal.
Denial frequency intensity by specialty and payer category. Hover or tap any cell to reveal the typical VCS mitigation playbook for that combination.
Anonymized conversion rates across the full appeal journey. Each stage shows historical VCS performance from initial submission through external review.
Transparency about the numbers is part of how VCS operates. Here's exactly what this data represents.
All figures are aggregated from VCS-supported workflows across active client practices. Individual case data is anonymized before analysis — no PHI is used, stored, or transmitted. Payer names are replaced with category labels.
Data is refreshed quarterly from the production workflow database. Figures represent trailing 12-month performance unless otherwise noted. Seasonal variation and payer policy changes can affect individual quarters.
"Up to" language is used throughout. Peak figures reflect best-observed performance cohorts. Median performance for comparable practice types is typically 15–20% below the reported peak. Sample sizes vary by payer category.
All aggregation follows HIPAA de-identification standards. No individual patient, provider, or practice data is surfaced. VCS operates a strict internal document access audit trail — every clinical record access is logged and role-gated.
Three ways VCS translates this data into operational outcomes for specialty practices.
Submit right the first time. Our payer intelligence informs pre-submission checklists tailored to each payer's documented denial triggers.
When a denial lands, payer intelligence determines the fastest path to overturn — first appeal, P2P, or external review. We know which route wins for which payer.
CFO-grade visibility. Payer mix + historical approval rates = projected revenue at risk, SLA-adjusted recovery timelines, and denial trend forecasting by quarter.
VCS will map your current payer mix against this intelligence and show you exactly where your revenue is at risk — before the next denial cycle hits.